Etiologic factors of hyposalivation and consequences for oral health

Quintessence International

Volumn 41, Issue 4, 2010, Pages 321-333

  Tschoppe, Peter ^a   Wolgin, Michael ^a   Pischon, Nicole ^a   Kielbassa, Andrej M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Caries; Drugs; Hyposalivation; Microflora; Periodontitis; Radiotherapy; Saliva substitutes; Sj gren syndrome; Xerostomia

Indexed keywords

SALIVA PROTEIN; SALIVA SUBSTITUTE;

CHEMISTRY; HEALTH; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SALIVA; XEROSTOMIA;

HUMANS; ORAL HEALTH; SALIVA; SALIVA, ARTIFICIAL; SALIVARY PROTEINS AND PEPTIDES; XEROSTOMIA;

EID: 77953269710     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Brosky ME. The role of saliva in oral health:Strategies for prevention and management of xerostomia. J Support Oncol 2007; 5: 215-225.
2. Dowd FJ. Saliva and dental caries. Dent Clin North Am 1999; 43: 579-597.
3. Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002; 8: 117-129.
4. Abiko Y, Nishimura M, Kaku T. Defensins in saliva and the salivary glands. Med Electron Microsc 2003; 36: 247-252.
5. Mese H, Matsuo R. Salivary secretion, taste and hyposalivation. J Oral Rehabil 2007; 34: 711-723.
6. Schneyer LH. Method for the collection of separate submaxillary and sublingual salivas in man. J Dent Res 1955; 34: 257-261.
7. Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: A new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007; 383: 30-40.
8. Nederfors T. Xerostomia and hyposalivation. Adv Dent Res 2000; 14: 48-56.
9. Goode RL, Smith RA. The surgical management of sialorrhea. Laryngoscope 1970; 80: 1078-1089.
10. Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc 2008; 139(suppl): 18-24.
11. Gardner MS, Rowland MD, Siu AY, Bundy JL, Wagener DK, Stephenson JL. Comprehensive defensin assay for saliva. Anal Chem 2009; 81: 557-566.
12. Eliasson L, Birkhed D, Osterberg T, Carlen A. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly. Eur J Oral Sci 2006; 114: 494-499.
13. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary proteins: Protective and diagnostic value in cariology? Caries Res 2004; 38: 247-253.
14. Gafni RI, Papanicolaou DA, Nieman LK. Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents. J Pediatr 2000; 137: 30-35.
15. Vining RF, McGinley R, Rice BV. Saliva estriol measurements:An alternative to the assay of serum unconjugated estriol in assessing feto-placental function. J Clin Endocrinol Metab 1983; 56: 454-460.
16. Hofman LF. Human saliva as a diagnostic specimen. J Nutr 2001; 131: 1621-1625.
17. Groschl M. Current status of salivary hormone analysis. Clin Chem 2008; 54: 1759-1769.
18. Groschl M, Kohler H, Topf HG, Rupprecht T, Rauh M. Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. J Pharm Biomed Anal 2008; 47: 478-486.
19. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992; 71: 1363-1369.
20. Drummond JR, Chisholm DM. A qualitative and quantitative study of the ageing human labial salivary glands. Arch Oral Biol 1984; 29: 151-155.
21. Eveson JW. Xerostomia. Periodontol 2000 2008; 48: 85-91.
22. Tschoppe P, Meyer-Lückel H, Kielbassa A. Xerostomia and saliva substitutes [in German]. In:Heidemann D (ed). Zahnärztekalender 2008. Cologne:Deutscher Zahnärzte, 2008: 235-253.
23. Osterberg T, Landahl S, Hedegard B. Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment. J Oral Rehabil 1984; 11: 157-170.
24. Parvinen T, Larmas M. Age dependency of stimulated salivary flow rate, pH, and lactobacillus and yeast concentrations. J Dent Res 1982; 61: 1052-1055.
25. Osterberg T, Birkhed D, Johansson C, Svanborg A. Longitudinal study of stimulated whole saliva in an elderly population. Scand J Dent Res 1992; 100: 340-345.
26. Ben-Aryeh H, Shalev A, Szargel R, Laor A, Laufer D, Gutman D. The salivary flow rate and composition of whole and parotid resting and stimulated saliva in young and old healthy subjects. Biochem Med Metab Biol 1986; 36: 260-265.
27. Sevon L, Laine MA, Karjalainen S, et al. Effect of age on flow-rate, protein and electrolyte composition of stimulated whole saliva in healthy, non-smoking women. Open Dent J 2008; 2: 89-92.
28. Navazesh M, Mulligan RA, Kipnis V, Denny PA, Denny PC. Comparison of whole saliva flow rates and mucin concentrations in healthy Caucasian young and aged adults. J Dent Res 1992; 71: 1275-1278.
29. Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res 1994; 73: 1416-1420.
30. Pedersen W, Schubert M, Izutsu K, Mersai T, Truelove E. Age-dependent decreases in human submandibular gland flow rates as measured under resting and post-stimulation conditions. J Dent Res 1985; 64: 822-825.
31. Dodds MW, Yeh CK, Johnson DA. Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 2000; 28: 373-381.
32. Ben-Aryeh H, Schiller M, Shasha S, Szargel R, Gutman D. Salivary composition in patients with essential hypertension and the effect of Pindolol. J Oral Med 1981; 36: 76-78.
33. van Hooff M, van Baak MA, Schols M, Rahn KH. Studies of salivary flow in borderline hypertension:Effects of drugs acting on structures innervated by the autonomic nervous system. Clin Sci (Lond) 1984; 66: 599-604.
34. Niedermeier W, Dreizen S, Stone RE, Spies TD. Sodium and potassium concentrations in the saliva of normotensive and hypertensive subjects. Oral Surg Oral Med Oral Pathol 1956; 9: 426-431.
35. Streckfus CF, Wu AJ, Ship JA, Brown LJ. Comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons. Oral Surg Oral Med Oral Pathol 1994; 77: 615-619.
36. Turner M, Jahangiri L, Ship JA. Hyposalivation, xerostomia and the complete denture: A systematic review. J Am Dent Assoc 2008; 139: 146-150.
37. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth-2nd edition. Gerodontology 1997; 14: 33-47.
38. Lewis IK, Hanlon JT, Hobbins MJ, Beck JD. Use of medications with potential oral adverse drug reactions in community-dwelling elderly. Spec Care Dentist 1993; 13: 171-176.
39. Gilbert GH, Heft MW, Duncan RP. Mouth dryness as reported by older Floridians. Community Dent Oral Epidemiol 1993; 21: 390-397.
40. Streckfus CF. Salivary function and hypertension: A review of the literature and a case report. J Am Dent Assoc 1995; 126: 1012-1017.
41. Scully C. Drug effects on salivary glands:Dry mouth. Oral Dis 2003; 9: 165-176.
42. Kielbassa AM (ed). Radiotherapy of the Head and Neck. Implications for Dentists, Ear-Nose-Throat Physicians, and Radiologists [in German].Hannover:Schlütersche, 2004: 59-69.
43. Franzen L, Gustafsson H, Sundstrom S, Karlsson M, Littbrand B, Henriksson R. Fractionated irradiation and late changes in rat parotid gland: Effects on the number of acinar cells, potassium efflux, and amylase secretion. Int J Radiat Biol 1993; 64: 93-101.
44. Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol 2006; 7: 326-335.
45. Helenius LM, Hietanen JH, Helenius I, et al. Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: A comparison with patients with rheumatoid arthritis or mixed connective tissue disease. Ann Rheum Dis 2001; 60: 744-749.
46. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996; 55: 116-121.
47. Jonsson R, Kroneld U, Tarkowski A. Histological and functional features of salivary glands in rheumatic patients with oral sicca symptoms. Scand J Rheumatol 1988; 17: 387-391.
48. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Wolff A. Sjogren's syndrome: The diagnostic potential of early oral manifestations preceding hyposalivation/ xerostomia. J Oral Pathol Med 2005; 34: 1-6.
49. Almstahl A, Wikstrom M. Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins. Arch Oral Biol 2003; 48: 337-344.
50. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006; 45: 1077-1086.
51. Helenius LM, Meurman JH, Helenius I, et al. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 2005; 63: 284-293.
52. MacFarlane TW, Mason DK. Changes in the oral flora in Sjogren's syndrome. J Clin Pathol 1974; 27: 416-419.
53. Eliasson L, Carlen A, Almstahl A, Wikstrom M, Lingstrom P. Dental plaque pH and micro-organisms during hyposalivation. J Dent Res 2006; 85: 334-338.
54. Almstahl A, Wikstrom M. Oral microflora in subjects with reduced salivary secretion. J Dent Res 1999; 78: 1410-1416.
55. Ben-Aryeh H, Serouya R, Kanter Y, Szargel R, Laufer D. Oral health and salivary composition in diabetic patients. J Diabetes Complications 1993; 7: 57-62.
56. Mata AD, Marques D, Rocha S, et al. Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol Cell Biochem 2004; 261: 137-142.
57. Tenovuo J, Lehtonen OP, Viikari J, Larjava H, Vilja P, Tuohimaa P. Immunoglobulins and innate antimicrobial factors in whole saliva of patients with insulin-dependent diabetes mellitus. J Dent Res 1986; 65: 62-66.
58. Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med 2006; 23: 455-459.
59. Lenander-Lumikari M, Ihalin R, Lahteenoja H. Changes in whole saliva in patients with coeliac disease. Arch Oral Biol 2000; 45: 347-354.
60. von Knorring L, Mornstad H. Qualitative changes in saliva composition after short-term administration of imipramine and zimelidine in healthy volunteers. Scand J Dent Res 1981; 89: 313-320.
61. von Knorring L, Mornstad H. Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission. Neuropsychobiology 1986; 15: 146-154.
62. de Almeida Pdel V, Gregio AM, Brancher JA, et al. Effects of antidepressants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 58-65.
63. Nederfors T, Nauntofte B, Twetman S. Effects of furosemide and bendroflumethiazide on saliva flow rate and composition. Arch Oral Biol 2004; 49: 507-513.
64. Nederfors T, Dahlof C, Ericsson T, Twetman S. Effects of the antihypertensive drug captopril on human salivary secretion rate and composition. Eur J Oral Sci 1995; 103: 351-354.
65. Nederfors T, Dahlof C. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition. Arch Oral Biol 1992; 37: 579-584.
66. Nederfors T, Dahlof C, Twetman S. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unstimulated whole saliva flow rate and protein composition. Scand J Dent Res 1994; 102: 235-237.
67. Laine P, Meurman JH, Tenovuo J, et al. Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs. Eur J Cancer B Oral Oncol 1992; 28B: 125-128.
68. Hannig M, Dounis E, Henning T, Apitz N, Stosser L. Does irradiation affect the protein composition of saliva? Clin Oral Investig 2006; 10: 61-65.
69. Chitra S, Shyamala Devi CS. Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer. Indian J Dent Res 2008; 19: 213-218.
70. Makkonen TA, Tenovuo J, Vilja P, Heimdahl A. Changes in the protein composition of whole saliva during radiotherapy in patients with oral or pharyngeal cancer. Oral Surg Oral Med Oral Pathol 1986; 62: 270-275.
71. Schmidberger H, Rave-Frank M, Kim S, Hille A, Pradier O, Hess CF. Radiation-induced mucositis and neutrophil granulocytes in oral mucosa [in German]. Strahlenther Onkol 2003; 179: 667-672.
72. Brown LR, Dreizen S, Rider LJ, Johnston DA. The effect of radiation-induced xerostomia on saliva and serum lysozyme and immunoglobulin levels. Oral Surg Oral Med Oral Pathol 1976; 41: 83-92.
73. Himi T, Kukuminato Y, Kita H, Yoshioka I, Kataura A. Effect of radiotherapy on the levels of secretory immunoglobulin A against indigenous and virulent streptococci. Otolaryngol Head Neck Surg 1997; 117: 433-437.
74. Brown LR, Dreizen S, Handler S, Johnston DA. Effect of radiation-induced xerostomia on human oral microflora. J Dent Res 1975; 54: 740-750.
75. Almstahl A, Wikstrom M, Fagerberg-Mohlin B. Microflora in oral ecosystems in subjects with radiation-induced hyposalivation. Oral Dis 2008; 14: 541-549.
76. Brown LR, Dreizen S, Daly TE, et al. Interrelations of oral microorganisms, immunoglobulins, and dental caries following radiotherapy. J Dent Res 1978; 57: 882-893.
77. Al-Nawas B, Grotz KA. Prospective study of the long term change of the oral flora after radiation therapy. Support Care Cancer 2006; 14: 291-296.
78. Tschoppe P, Meyer-Lueckel H, Kielbassa AM. Effect of carboxymethylcellulose-based saliva substitutes on predemineralised dentin evaluated by microradiography. Arch Oral Biol 2008; 53: 250-256.
79. Sreebny LM. Recognition and treatment of salivary induced conditions. Int Dent J 1989; 39: 197-204.
80. Davies A. Saliva substitutes or stimulants. Palliat Med 1997; 11: 254-255.
81. Nieuw Amerongen AV, Veerman EC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003; 11: 226-231.
82. Urquhart D, Fowler CE. Review of the use of polymers in saliva substitutes for symptomatic relief of xerostomia. J Clin Dent 2006; 17: 29-33.
83. Momm F, Volegova-Neher NJ, Schulte-Monting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol 2005; 181: 231-236.
84. Vissink A, s'Gravenmade EJ, Panders AK, et al. A clinical comparison between commercially available mucin-and CMC-containing saliva substitutes. Int J Oral Surg 1983; 12: 232-238.
85. Visch LL, s'Gravenmade EJ, Schaub RM, Van Putten WL, Vissink A. A double-blind crossover trial of CMCand mucin-containing saliva substitutes. Int J Oral Maxillofac Surg 1986; 15: 395-400.
86. Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998; 29: 383-388.
87. Epstein JB, Stevenson-Moore P. A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction. Spec Care Dentist 1992; 12: 21-23.
88. Furumoto EK, Barker GJ, Carter-Hanson C, Barker BF. Subjective and clinical evaluation of oral lubricants in xerostomic patients. Spec Care Dentist 1998; 18: 113-118.
89. Joyston-Bechal S, Kidd EA. The effect of three commercially available saliva substitutes on enamel in vitro. Br Dent J 1987; 163: 187-190.
90. Kielbassa AM, Shohadai SP, Schulte-Mönting J. Effect of saliva substitutes on mineral content of demineralized and sound dental enamel. Support Care Cancer 2001; 9: 40-47.
91. Meyer-Lueckel H, Schulte-Mönting J, Kielbassa AM. The effect of commercially available saliva substitutes on pre-demineralized bovine dentin in vitro. Oral Dis 2002; 8: 192-198.
92. Tschoppe P, Meyer-Lueckel H, Toll R, Kielbassa AM. In vitro analysis of an new saliva substitute (Saliva natura) on enamel and dentin [in German]. Laryngorhinootologie 2007; 86: 723-727.
93. Tschoppe P, Kielbassa AM, Toll R, Meyer-Lueckel H. Modification of the mineralizing capacity of a saliva substitute (saliva) [in German]. Laryngorhinootologie 2009; 88: 717-722.
94. Tschoppe P, Kielbassa AM, Meyer-Lueckel H. Evolution of the remineralizing capacities of modified saliva substitutes in vitro. Arch Oral Biol 2009; 54: 810-816.